# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division A: Confirmed case

Extent: E+W+S+N.I.

At least one of the following:
Detection of Zika virus nucleic acid in a clinical specimen;
Detection of Zika virus antigen in a clinical specimen;
Isolation of Zika virus from a clinical specimen;
Detection of Zika virus specific IgM antibodies in serum sample(s) AND confirmation by neutralization test;
Seroconversion or four-fold increase in the titre of Zika specific antibodies in paired serum samples.

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.56/division/2/division/A (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.56/division-2/division-A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.